王新民，男，汉族，1995年3月生，内蒙古包头市人，博士
邮箱：wangxinmin@imust.edu.cn
教育经历：
2017-09至2022-06，中国药科大学，生物学，博士
2013-09至2017-06，中国药科大学，环境科学，学士
工作经历：
2022-07至今，bv伟德国际体育，bevictor伟德，讲师
研究方向：
多肽药物的设计与发现
自身免疫类疾病治疗研究
代表论著：
Wang, Xinmin; Wang, Ying; Hu, Jialiang; Xu, Hanmei; An antitumor peptide RS17-targeted CD47, design, synthesis, and antitumor activity, Cancer Medicine, 2021, 10(6): 2125-2136. (IF = 4.711; 期刊论文)
Peiwei Yang; Ying Wang; Zheng Yao; Xinmei Gao; Chen Liu; Xinmin Wang; Heming Wu; Xu Ding; Jialiang Hu; Bingjing Lin; Qian Li; Mengwei Li; Xin Li; Xiangying Chen; Weiyan Qi; Weiguang Li; Jianpeng Xue; Hanmei Xu; Enhanced Safety and Antitumor Efficacy of Switchable Dual Chimeric Antigen Receptor-Engineered T Cells against Solid Tumors through a Synthetic Bifunctional PD-L1-Blocking Peptide, Journal of the American Chemical Society, 2020, 142(44): 18874-18885. (IF = 16.383; 期刊论文)
Ge, Chuang; Hao, Jingchao; Wu, Xiaodong; Li, Chencheng; Zhi, Rui; Yu, Pengcheng; Wang, Xinmin; Hu, Jialiang; Xu, Hanmei; A novel arthritis model induced by wind, damp, cold and heat in female rats, Laboratory Animals, 2020, 54(5): 433-442. (IF = 2.908; 期刊论文)
徐寒梅,王新民. 一种具有抗CD47免疫检查点拮抗活性的多肽RS-17及其应用[P]. 江苏省：CN110981942B, 2022-07-08. (发明专利)
